Academic literature on the topic 'Propranolol'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Propranolol.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Propranolol"

1

Kobeleva, Tatyana A., Alik I. Sichko, Marina I. Popova, and Elena M. Shapovalova. "Development and validation of a spectrophotometric method for the analysis of propranolol in a new soft dosage form "Propranozol"." Человек и его здоровье 24, no. 4 (2021): 83–90. http://dx.doi.org/10.21626/vestnik/2021-4/11.

Full text
Abstract:
At present, the issue of creating and introducing into medical practice domestically produced drugs, the quality of man-ufacture of which is established using objective, highly sensitive optical physical and chemical methods, becomes relevant. Objective: to develop a spectrophotometric method for analysis of propranololol in the ointment "Propranozol" made on the basis of "Tizol" gel. Materials and methods. Pharmaceutical substance propranolol, gel "Tizol", soft dosage form "Propranosol" containing 0.5% of beta-adrenoblocker in titanium-containing base were used in the study. The analysis was
APA, Harvard, Vancouver, ISO, and other styles
2

Gajkiewicz, Magdalena, Radosław Zaucha, Julia Silldorff, et al. "Propranolol in treating various symptoms associated with autism spectrum disorder (ASD)." Quality in Sport 19 (August 17, 2024): 53778. http://dx.doi.org/10.12775/qs.2024.19.53778.

Full text
Abstract:
Introduction and purpose This review provides an in-depth exploration of the pharmacology of propranolol, elucidating its mechanisms of action and clinical implications beyond its conventional indications, contextualizing propranolol’s role in ASD management. State of knowledge Propranolol is a non-cardioselective β-adrenergic receptor antagonist, commonly used among the population. Propranolol's mechanisms include reducing cardiac workload, vasoconstriction, and membrane stabilizing properties, which suggest its utility in managing anxiety. ASD, characterized by deficits in social interaction
APA, Harvard, Vancouver, ISO, and other styles
3

Li, Mi, and Yanqin Ji. "Propranolol Inhibits the Growth of Cervical Cancer Cells by Inhibiting Cyclic Guanosine Monophosphate/Protein Kinase G (cGMP/PKG) Pathway." Journal of Biomaterials and Tissue Engineering 12, no. 2 (2022): 422–26. http://dx.doi.org/10.1166/jbt.2022.2916.

Full text
Abstract:
This study assesses the therapeutic effect of propranolol on cervical cancer and its mechanism. Propranolol’s effect on cervical cancer was evaluated by MTT, Western blotting, flow cytometry and colony formation. By searching Drug Bank and String, cGMP/PKG signaling might be downstream targets of propranolol for subsequent analysis. Our results found that propranolol could significantly inhibit Hela and SiHA cell vitality and clone formation in a dose dependent manner. Further, Annexin V-PE/7-AAD Apoptosis Detection assay showed that propranolol could increase Hela and SiHA cell apoptosis. Fin
APA, Harvard, Vancouver, ISO, and other styles
4

Sowinski, Kevin M., and Brad S. Burlew. "Impact of CYP2D6 Poor Metabolizer Phenotype on Propranolol Pharmacokinetics and Response." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17, no. 6 (1997): 1305–10. http://dx.doi.org/10.1002/j.1875-9114.1997.tb03097.x.

Full text
Abstract:
We conducted an open‐label study to determine the impact of cytochrome P‐4502D6 (CYP2D6) on propranolol pharmacokinetics and response in 12 healthy men with CYP2D6 extensive metabolizer (EM) phenotype and 3 healthy men with CYP2D6 poor metabolizer (PM) phenotype. Subjects received R,S‐propranolol hydrochloride 80 mg every 8 hours for 16 doses. After the sixteenth dose, blood and urine samples were collected for 24 hours, and serum propranolol and urine metabolite concentrations were determined by chiral high‐performance liquid chromatography. Heart rate response to treadmill exercise was measu
APA, Harvard, Vancouver, ISO, and other styles
5

Hurley, Elisa A. "Pharmacotherapy to Blunt Memories of Sexual Violence: What's a Feminist to Think?" Hypatia 25, no. 3 (2010): 527–52. http://dx.doi.org/10.1111/j.1527-2001.2010.01108.x.

Full text
Abstract:
It has recently been discovered that propranolol—a beta-blocker traditionally used to treat cardiac arrhythmias and hypertension—might disrupt the formation of the emotionally disturbing memories that typically occur in the wake of traumatic events and consequently prevent the onset of trauma-induced psychological injuries such as Post-traumatic Stress Disorder. One context in which the use of propranolol is generating interest in both the popular and scientific press is sexual violence. Nevertheless, feminists have so far not weighed in on propranolol. I suggest that the time is ripe for a ca
APA, Harvard, Vancouver, ISO, and other styles
6

Alotaibi, Hadil Faris, Haifa Alotaibi, Khaled M. Darwish, et al. "The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against Pseudomonas aeruginosa and Serratia marcescens." Biomedicines 11, no. 12 (2023): 3161. http://dx.doi.org/10.3390/biomedicines11123161.

Full text
Abstract:
The development of bacterial resistance is an increasing global concern that requires discovering new antibacterial agents and strategies. Bacterial quorum sensing (QS) systems play important roles in controlling bacterial virulence, and their targeting could lead to diminishing bacterial pathogenesis. In this context, targeting QS systems without significant influence on bacterial growth is assumed as a promising strategy to overcome resistance development. This study aimed at evaluating the anti-QS and anti-virulence activities of the β-adrenoreceptor antagonist propranolol at sub-minimal in
APA, Harvard, Vancouver, ISO, and other styles
7

Kumar, Lalit, and Puneet Utreja. "Oleic Acid Vesicles for Transdermal Delivery of Propranolol Hydrochloride: Development and Characterization." Current Drug Therapy 15, no. 3 (2020): 238–48. http://dx.doi.org/10.2174/1574885514666190722164119.

Full text
Abstract:
Background: Pharmaceutical scientists are exploring transdermal route for treatment of various systemic diseases nowadays. Transdermal nanocarrier systems show various advantages like bioavailability enhancement of drugs, avoidance of first pass hepatic metabolism, and reduction of dosing frequency of bioactive therapeutic molecules. Objective: The objective of the present research work was to encapsulate Propranolol hydrochloride into oleic acid vesicles and carry out in-vitro and in-vivo evaluation of oleic acid vesicular gel containing Propranolol hydrochloride. Method: Propranol hydrochlor
APA, Harvard, Vancouver, ISO, and other styles
8

Miguel-Puga, Adán, Gabriel Villafuerte, Mario Treviño, Emmanuel Ortega-Robles, and Oscar Arias-Carrión. "Effect of Propranolol on Motor Cortex Excitability in Essential Tremor: An Exploratory Study." Tremor and Other Hyperkinetic Movements 14 (January 2, 2024): 1. http://dx.doi.org/10.5334/tohm.829.

Full text
Abstract:
Background: Essential tremor, the world’s most prevalent movement disorder, lacks a clear understanding of its pathophysiology. Propranolol, a non-specific beta-blocker capable of crossing the blood-brain barrier, is a primary choice for essential tremor treatment. While its tremor-reducing effects are generally attributed to peripheral actions, various uses hint at central adrenergic effects. Nevertheless, propranolol’s precise impact on the central nervous system in essential tremor subjects remains unexplored. Methods: In this study, we employed transcranial magnetic stimulation to assess t
APA, Harvard, Vancouver, ISO, and other styles
9

Gulzar, G. M., Showkat A. Zargar, M. S. Alai, et al. "Effect of acute administration of propranolol, carvedilol, iso-sorbide dinitrate, “propranolol plus iso-sorbide dinitrate” and “carvedilol plus iso-sorbide dinitrate” on portal venus pressure." JMS SKIMS 16, no. 2 (2013): 80–85. http://dx.doi.org/10.33883/jms.v16i2.215.

Full text
Abstract:
Pharmacotherapy of portal hypertension in patients with cirrhosis includes beta-blockers, nitrates, somatastain analogues, alpha-blockers like prazocin. These drugs differ widely in their effectiveness, adverse effects and patient compliance. Beta-blockers particularly propranolol are the most commonly used drugs. Of late, carvedilol has been used and found to be superior to propranolol. The present study was aimed at assessing the effect of propranolol, carvedilol, iso-sorbide dinitrate; combination of “propranolol and iso-sorbide-dinitrate” and carvedilol and isosorbide dinitrate” on portal
APA, Harvard, Vancouver, ISO, and other styles
10

Rešić, Arnes, Zdenka Pleša Premilovac, Filip Jurić, and Marko Mesić. "Hipoglikemija – nuspojava terapije propranololom dojenačkih hemangioma – prikaz triju slučajeva." Paediatria Croatica 58, no. 4 (2014): 310–14. http://dx.doi.org/10.13112/pc.605.

Full text
Abstract:
Peroralno primijenjen propranolol u dozi od 1-3 mg/kg/dan terapija je izbora kompliciranih hemangioma dojenačke dobi. Prikazujemo dva bolesnika s nastankom simptomatske hipoglikemije i jednog bolesnika s nastankom konvulzija najvjerojatnije povezanihs hipoglikemijom, koji su na peroralnoj terapiji propranololom radi liječenja dojenačkih hemangioma. Iako se propranolol priličnodugo primjenjuje u drugim indikacijama, i čini se pouzdanim lijekom, baš zbog svoje neselektivnosti u djelovanju potrebno je prepoznati moguće i rjeđe nuspojave kao što je hipoglikemija, posebice u novim indikacijama za p
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Propranolol"

1

Lee, Daniel K. "Cellular Targets of Propranolol in Infantile Hemangioma." Thesis, Harvard University, 2013. http://dissertations.umi.com/gsas.harvard:11218.

Full text
Abstract:
Infantile hemangioma (IH) is a vascular neoplasm that affects 4-10 percent of infants. Propranolol, a non-selective beta-adrenergic receptor (AR) antagonist, was serendipitously discovered to accelerate regression of IH in 2008; however, its mechanism in IH is unclear.
APA, Harvard, Vancouver, ISO, and other styles
2

Schill, Thomas [Verfasser], and Jochen [Akademischer Betreuer] Rößler. "Die systemische Therapie infantiler Hämangiome mit Propranolol." Freiburg : Universität, 2010. http://d-nb.info/1123466033/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Khoury, Rayana Duarte. "O estresse crônico e a via de sinalização adrenérgica no desenvolvimento da lesão periapical /." São José dos Campos, 2017. http://hdl.handle.net/11449/152533.

Full text
Abstract:
Orientador: Marcia Carneiro Valera<br>Coorientadora: Renata Falchete do Prado<br>Banca: Eduardo Bresciani<br>Banca: Mariella Vieira Pereira Leão<br>Resumo: Os objetivos deste estudo são: 1) Esclarecer a possível associação entre o estresse crônico e a estimulação do Sistema Nervoso Simpático (SNS) e investigar sua interferência no desenvolvimento e progressão da lesão periapical; 2) Avaliar a quantidade de receptores para os neurotransmissores na região periapical; 3) Elucidar uma via farmacológica de modulação inflamatória através do uso de bloqueadores adrenérgicos. Trinta e dois ratos Wista
APA, Harvard, Vancouver, ISO, and other styles
4

Meimoun, Laurence. "Les migraines : comparaison des effets thérapeutiques du propranolol avec ceux d'autres antimigraineux." Paris 5, 1994. http://www.theses.fr/1994PA05P163.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ottilie, Henry. "Einfluß von Propranolol auf den Fastenstoffwechsel des Schafes." Doctoral thesis, Universitätsbibliothek Leipzig, 2004. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-36675.

Full text
Abstract:
Die therapeutische Beeinflußbarkeit einer Leberverfettung gilt weltweit als unbefriedigend ge-löst, so daß ein letaler Ausgang besonders bei Wiederkäuern teilweise nicht zu verhindern ist. Die Nutzung von beta-Rezeptorenblockern hat bisher mit dieser Indikation keinen Eingang in die Veterinärmedizin gefunden. In den vorliegenden Untersuchungen wurden deshalb die Auswirkungen einer unspezifischen Blockade der beta-adrenergen Rezeptoren auf die Lipolyse, die klinischen und hämatologi-schen Funktionen sowie Leber-, Eiweiß- und Mineralstoffwechsel bei fastenden Schafen ge-prüft. Insbesondere wurde
APA, Harvard, Vancouver, ISO, and other styles
6

Song, Karine. "Etudes pharmacotoxicologiques du propranolol et de ses enantiomères." Paris 5, 1997. http://www.theses.fr/1997PA05P126.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Martin, Paul D. "The application of molecular imprinted polymers to the solid phase extraction of drugs." Thesis, Keele University, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.250426.

Full text
Abstract:
Molecular imprinted polymers (MIPs), prepared to propranolol, were evaluated as solid phase extraction (SPE) phases. Monolithic MIPs were converted to particulate SPE materials by crushing, sieving, and sedimentation to remove fines. A high proportion (85%) of template propranolol was recovered with initial washes of the MIPs. Template leaching diminished with successive washes though low level leachings till compromised analysis of propranolol at trace levels (<5ng/mL). It was possible to retain propranolol on the MIPs following application in aqueous solution, biological matrices and organic
APA, Harvard, Vancouver, ISO, and other styles
8

Овечкін, Денис Вячеславович, Денис Вячеславович Овечкин, Denys Viacheslavovych Ovechkin, et al. "Propranolol-resistant infantile hemangiomas: the analysis of 2 cases." Thesis, Sumy State University, 2016. http://essuir.sumdu.edu.ua/handle/123456789/48495.

Full text
Abstract:
Infantile hemangiomas (IH) are the most common soft-tissue tumours of infancy. Although propranolol has been shown to treat IH effectively, there are a few cases of propranolol-resistant IH (PRIH) are mentioned in the literature. The incidence of PRIH in different studies is 0-9%. The objective of this study is to describe and analyze the clinical cases of PRIH. This prospective study was conducted in the department of Pediatric surgery at Sumy Region Children's Clinical Hospital (Ukraine) between September 2012 and January 2016.
APA, Harvard, Vancouver, ISO, and other styles
9

Yim, Júnior Alberto [UNIFESP]. "Efeitos da infusão intra-amigdalar do inibidor de síntese protéica anisomicina e da administração sistêmica do propranolol após a evocação sobre a expressão de uma preferência condicionada ao lugar induzida pela morfina." Universidade Federal de São Paulo (UNIFESP), 2007. http://repositorio.unifesp.br/handle/11600/23506.

Full text
Abstract:
Made available in DSpace on 2015-12-06T23:47:01Z (GMT). No. of bitstreams: 0 Previous issue date: 2007<br>Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)<br>Diversos estudos tem mostrado que memorias aversivas antigas, ja consolidadas, quando reativadas, retomam em um estado fragil, necessitando de uma nova rodada de consolidacao para que ela tome-se novamente estavel. Este fenomeno e denominado de reconsolidacao, sendo dependente tanto da sintese proteica quanto do sistema noradrenergico. A tarefa da preferencia condicionada pelo lugar e um tipo de condicionamento pavl
APA, Harvard, Vancouver, ISO, and other styles
10

Prey, Sorilla. "Propranolol dans les hemangiomes infantiles : tolérance et identification des voies thérapeutiques." Thesis, Bordeaux, 2014. http://www.theses.fr/2014BORD0342.

Full text
Abstract:
L'hémangiome capillaire infantile (IH) est une tumeur vasculaire bénigne courante. Les formes sévères sont traitées depuis 2008 par propranolol bien que le mécanisme d’action reste à ce jour inexpliqué. La 1ère partie de ma thèse est une étude de tolérance chez les enfants traités par propranolol dans le cadre de l'ATU française. L'analyse de cette base de données prospective de 922 enfants a permis de confirmer la bonne tolérance du propranolol dans la population pédiatrique, et de cibler les situations à risque de complication. La 2e partie est une étude de la signalisation adrénergique à pa
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Propranolol"

1

J, Delic, and Great Britain. Health and Safety Executive., eds. Propranolol: Criteria document for an occupational exposure limit. HSE Books, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Paradiso, Frances Lori. The central nervous system effects and pharmacokinetics of propranolol enantiomers. National Library of Canada = Bibliothèque nationale du Canada, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Angrini, Manar A. Effect of propranolol and other 5-HT antagonists of motivated and emotional behaviour. The Author], 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hassounah, Ahmed. The effect of propranolol on renal prostaglandin-E2, the reninangiotensin and kidney function in rabbit. University of Salford, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mathieu, Charlotte. Phase III-Studie zur Wirksamkeit und Sicherheit von oralem Propranolol bei Säuglingen mit schweren, proliferierenden Hämangiomen. s.n.], 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Polsak, Hans Z. Untersuchungen über die Eliminationskinetik, die Dosis-Wirkungsbeziehung und die Plasmahalbwertzeiten nach kumulativ intravenöser Applikation von Carteolol und Propranolol. [s.n.], 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pett, Burkhard. Der Einfluss von Propranolol auf die Dosiswirkungskurven der kardiovaskulären Effekte von Isoprenalin in Abhängigkeit von der dosis- und zeitabhängigen Besetzung von [beta]₁- und [beta]₂-Adrenozeptoren. [s.n.], 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hansen, Matthias. Monotherapie der Hyperthyreose mit R-Propranolol. 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pitschner, Heinz-Friedrich. Zeitwirkungsverlauf und Plasmakonzentrationskinetik von Propranolol und Carteolol beim Menschen. 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Graf, Kai-Ivo. Einfluss von Propranolol auf [beta]₂-adrenerge Rezeptorendichten und -funktion. 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Propranolol"

1

Maxwell, Robert A., and Shohreh B. Eckhardt. "Propranolol." In Drug Discovery. Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0469-5_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

McAllister-Williams, R. Hamish, Daniel Bertrand, Hans Rollema, et al. "Propranolol." In Encyclopedia of Psychopharmacology. Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_1846.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Beyer, Karl-Heinz. "Propranolol." In Biotransformation der Arzneimittel. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74386-3_275.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wilson, John Fawcett. "Propranolol." In The Immunoassay Kit Directory. Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0679-5_45.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Baron, Susannah. "Propranolol." In Handbook of Systemic Drug Treatment in Dermatology, 3rd ed. CRC Press, 2022. http://dx.doi.org/10.1201/9781003016786-31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Schneeweiss, Adam, and Gotthard Schettler. "Propranolol." In Developments in Cardiovascular Medicine. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-2063-0_36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

de Groot, Anton C. "Propranolol." In Monographs In Contact Allergy. CRC Press, 2022. http://dx.doi.org/10.1201/9781003158004-420.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Peter, Helga. "Propranolol." In Springer Reference Medizin. Springer Berlin Heidelberg, 2020. http://dx.doi.org/10.1007/978-3-642-54672-3_781-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Peter, Helga. "Propranolol." In Springer Reference Medizin. Springer Berlin Heidelberg, 2025. https://doi.org/10.1007/978-3-662-65186-5_781.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Fleig, H. A., and G. K. Krieglstein. "(—)-Propranolol in the Isolated Rabbit Iris." In Second European Glaucoma Symposium, Helsinki, May 1984. Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-009-5516-5_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Propranolol"

1

Rincón, D. A., M. C. Daza, and M. Doerr. "Application of the quantum theory of atoms in molecules (QTAIM) to the study of the enzymatic kinetic resolution of propranolol, an amino alcohol with pharmaceutical applications." In VIII Simpósio de Estrutura Eletrônica e Dinâmica Molecular. Universidade de Brasília, 2020. http://dx.doi.org/10.21826/viiiseedmol2020135.

Full text
Abstract:
Propranolol, ((R,S)-1-iso-propylamino-3-(1-naphthoxy)-2-propanol), is a β-adrenergic antagonist and is commercially available as a racemic mixture. Only the S-enantiomer has the desired therapeutic effect. Therefore, many researchers have been working on strategies to obtain S-propranolol with high enantiomeric purity. One approach to carry out the acetylation of (R,S)-Propranolol using Candida antarctica lipase B, CalB. This reaction leads to an enantiomeric purity of 96% at a relatively low conversion rate of 30 %. In our research group, we have been studying this reaction. The CalB active s
APA, Harvard, Vancouver, ISO, and other styles
2

Shi, Juntao. "Propranolol and nifedipine efficacy against hypertension." In International Conference on Biological Engineering and Medical Science (ICBIOMed2022), edited by Gary Royle and Steven M. Lipkin. SPIE, 2023. http://dx.doi.org/10.1117/12.2669574.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zapata-Romero, Gilberto A., Markus Doerr, and Martha C. Daza. "Enantioselective lipase-catalyzed O-acylation of (RS)-propranolol: analysis of the hydrogen bonds essential for catalysis." In VIII Simpósio de Estrutura Eletrônica e Dinâmica Molecular. Universidade de Brasília, 2020. http://dx.doi.org/10.21826/viiiseedmol2020131.

Full text
Abstract:
We investigated the effect of the acyl group size in the enantioselectivity of the acylation of propranolol, an amino alcohol used as β-adrenergic blocking agent. We applied a methodology frequently used to model enantioselectivity that is based on the hydrogen bonds present in the tetrahedral intermediate, which occurs in lipase-catalyzed reactions. We sampled the conformations of the tetrahedral intermediate corresponding to the esterification of both enantiomers of propranolol with ethanoyl and butanoyl, employing molecular dynamics simulation together with a quantum mechanics/molecular mec
APA, Harvard, Vancouver, ISO, and other styles
4

Kevrić, Andrea, and Jelena Roganović. "321 Threatment of infantile hemangiomas with propranolol." In 10th Europaediatrics Congress, Zagreb, Croatia, 7–9 October 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-europaediatrics.321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

He, Huarui, Georg Uray та Otto S. Wolfbeis. "Enantio-selective optode for the β-blocker propranolol". У Microlithography '91, San Jose,CA, редактори Robert A. Lieberman та Marek T. Wlodarczyk. SPIE, 1991. http://dx.doi.org/10.1117/12.24805.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

LI, Xiaojuan, Xiaorui XIE, Jin REN, Liling REN, and Jian CAO. "Effects of Propranolol on Osteoclasts Cultured in Vitro." In International Conference on Biological Engineering and Pharmacy 2016 (BEP 2016). Atlantis Press, 2017. http://dx.doi.org/10.2991/bep-16.2017.6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Calderon Barahona, G. M., R. Ali, C. Ortega Giron, et al. "Beta-Blocked: A Severe Propranolol Overdose Case Report." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5699.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Huang, Dushu, Wei Liu, Lihua Yao, Yong Min, Ruimin Xiao, and Yashun Chen. "Enantioseparation of Propranolol Enantiomers Using Hollow Fiber Membrane Contactor." In 2012 International Conference on Biomedical Engineering and Biotechnology (iCBEB). IEEE, 2012. http://dx.doi.org/10.1109/icbeb.2012.197.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Abidin, N., D. Jayachandran, and P. Shah. "G134 Oral propranolol in the management of infantile haemangiomas." In Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference and exhibition, 13–15 May 2019, ICC, Birmingham, Paediatrics: pathways to a brighter future. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2019. http://dx.doi.org/10.1136/archdischild-2019-rcpch.130.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Alonso Peralta, CA, T. Gimenez Poderós, D. Gómez, et al. "4CPS-135 Perphenazine and propranolol poisoning: a case report." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.236.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Propranolol"

1

Aikins, Deane. Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada612332.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Aikins, Deane. Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada543119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Aikins, Deane. Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada561958.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mundie, Thomas G., Adolph J. Januszkiewica, and Gary R. Ripple. Effects of Epinephrine, Phenoxybenzamine and Propranolol on Maximal Exercise in Sheep. Defense Technical Information Center, 1992. http://dx.doi.org/10.21236/ada261573.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Aikins, Deane. Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada598741.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Aikins, Deane. Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada615056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pitman, Roger K. A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada487404.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Liu, Xia, Hai-Xu Chen, and Bo Chen. Impact of combined propranolol and oxytocin on the process and outcomes of labor: a meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.9.0107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Treadwell, Jonathan R., Amy Y. Tsou, Benjamin Rouse, et al. Behavioral Interventions for Migraine Prevention. Agency for Healthcare Research and Quality (AHRQ), 2024. http://dx.doi.org/10.23970/ahrqepccer270.

Full text
Abstract:
Objectives. Behavioral interventions for migraine prevention can offer an important alternative or complement to medications. An updated systematic review is needed to support evidencebased guidance for clinicians and identify evidence gaps for future research. Data Sources. MEDLINE, Embase, PsycINFO, PubMed, the Cochrane Database of Systematic Reviews, clinicaltrials.gov, and grey literature sources for randomized trials published from January 1, 1975, to August 24, 2023. Review Methods. A multidisciplinary expert panel including adult and pediatric clinical psychologists, adult and pediatric
APA, Harvard, Vancouver, ISO, and other styles
10

Propranolol generally safe in treating childhood haemangioma birthmarks. National Institute for Health Research, 2017. http://dx.doi.org/10.3310/signal-000363.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!